Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Monoamine Oxidase Inhibitors—Revisiting a Therapeutic Principle
Michael Entzeroth, Anil K. Ratty
Open Journal of Depression (2017) Vol. 06, Iss. 02, pp. 31-68
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Morpholine as ubiquitous pharmacophore in medicinal chemistry: Deep insight into the structure-activity relationship (SAR)
Archana Kumari, Rajesh K. Singh
Bioorganic Chemistry (2020) Vol. 96, pp. 103578-103578
Closed Access | Times Cited: 171
Antidepressant drugs as emerging contaminants: Occurrence in urban and non-urban waters and analytical methods for their detection
Carlos Castillo-Zacarías, Mario E. Barocio, Enrique Hidalgo-Vázquez, et al.
The Science of The Total Environment (2020) Vol. 757, pp. 143722-143722
Closed Access | Times Cited: 146
Monoamine oxidase‐B inhibitors as potential neurotherapeutic agents: An overview and update
Rati Kailash Prasad Tripathi, Senthil Raja Ayyannan
Medicinal Research Reviews (2019) Vol. 39, Iss. 5, pp. 1603-1706
Closed Access | Times Cited: 106
A second life for MAO inhibitors? From CNS diseases to anticancer therapy
Sabina Sblano, Angelina Boccarelli, Francesco Mesiti, et al.
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116180-116180
Open Access | Times Cited: 8
Drug-drug interactions between classic psychedelics and psychoactive drugs: a systematic review
Andreas Halman, Geraldine Kong, Jerome Sarris, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 17
Roles of selected non-P450 human oxidoreductase enzymes in protective and toxic effects of chemicals: review and compilation of reactions
Slobodan Rendić, Rachel D. Crouch, F. Peter Guengerich
Archives of Toxicology (2022) Vol. 96, Iss. 8, pp. 2145-2246
Open Access | Times Cited: 25
Drug–drug interactions involving classic psychedelics: A systematic review
Andreas Halman, Geraldine Kong, Jerome Sarris, et al.
Journal of Psychopharmacology (2023) Vol. 38, Iss. 1, pp. 3-18
Open Access | Times Cited: 14
A review of monoamine oxidase (MAO) inhibitors in tobacco or tobacco smoke
Sa Weon Hong, Paul Teesdale‐Spittle, Rachel Page, et al.
NeuroToxicology (2022) Vol. 93, pp. 163-172
Closed Access | Times Cited: 19
An update on drug repurposing in Parkinson’s disease: Preclinical and clinical considerations
Michela Salvadè, Mónica Di Luca, Fabrizio Gardoni
Biomedicine & Pharmacotherapy (2025) Vol. 183, pp. 117862-117862
Closed Access
Does drug repurposing bridge the gaps in management of Parkinson’s disease? Unravelling the facts and fallacies
Bushra Bashir, Sukriti Vishwas, Gaurav Gupta, et al.
Ageing Research Reviews (2025) Vol. 105, pp. 102693-102693
Closed Access
Attenuation of Ischemic Stroke-Caused Brain Injury by a Monoamine Oxidase Inhibitor Involves Improved Proteostasis and Reduced Neuroinflammation
Yanying Liu, Shelley Feng, Kalpana Subedi, et al.
Molecular Neurobiology (2019) Vol. 57, Iss. 2, pp. 937-948
Open Access | Times Cited: 32
Phytochemical screening and effect of Viscum album L. on monoamine oxidase A and B activity and serotonin, dopamine and serotonin receptor 5-HTR1A levels in Galleria mellonealla (Lepidoptera)
Anna Szurpnicka, Anna Katarzyna Wrońska, Katarzyna Buś, et al.
Journal of Ethnopharmacology (2022) Vol. 298, pp. 115604-115604
Open Access | Times Cited: 18
Development of a Novel Class of Pyridazinone Derivatives as Selective MAO-B Inhibitors
Mehmet Abdullah Alagöz, Jong‐Min Oh, Yaren Nur Zenni, et al.
Molecules (2022) Vol. 27, Iss. 12, pp. 3801-3801
Open Access | Times Cited: 16
Antidepressant-like effect of dehydrozingerone from Zingiber officinale by elevating monoamines in brain: in silico and in vivo studies
Sudheer Moorkoth, N. Sai Prathyusha, Suman Manandhar, et al.
Pharmacological Reports (2021) Vol. 73, Iss. 5, pp. 1273-1286
Open Access | Times Cited: 23
Drug reprofiling history and potential therapies against Parkinson’s disease
Komal Latif, Aman Ullah, Anastasiia D. Shkodina, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 14
Insights into the Mechanism of the Therapeutic Potential of Herbal Monoamine Oxidase Inhibitors in Neurological Diseases
Ashi Mannan, Thakur Gurjeet Singh, Varinder Singh, et al.
Current Drug Targets (2021) Vol. 23, Iss. 3, pp. 286-310
Closed Access | Times Cited: 18
Synthesis, molecular modelling and biological activity of some pyridazinone derivatives as selective human monoamine oxidase-B inhibitors
Zeynep Özdemir, Mehmet Abdullah Alagöz, Harun Uslu, et al.
Pharmacological Reports (2020) Vol. 72, Iss. 3, pp. 692-704
Closed Access | Times Cited: 16
Modeling the Bioactivation and Subsequent Reactivity of Drugs
Tyler B. Hughes, Noah R. Flynn, Na Le Dang, et al.
Chemical Research in Toxicology (2021) Vol. 34, Iss. 2, pp. 584-600
Open Access | Times Cited: 15
Review on Preclinical and Clinical Evidence of Food (Beverages, Fruits and Vegetables) and Drug Interactions: Mechanism and Safety
Yogesh Chand Yadav, Kamla Pathak, Devender Pathak
Current Drug Therapy (2019) Vol. 15, Iss. 1, pp. 12-27
Closed Access | Times Cited: 15
Marine natural products with monoamine oxidase (MAO) inhibitory activity
Ahreum Hong, Le Cam Tu, Inho Yang, et al.
Pharmaceutical Biology (2020) Vol. 58, Iss. 1, pp. 716-720
Open Access | Times Cited: 13
In silico study to identify new monoamine oxidase type a (MAO-A) selective inhibitors from natural source by virtual screening and molecular dynamics simulation
Khurshid Jalal, Kanwal Khan, Darakhshan Jabeen Haleem, et al.
Journal of Molecular Structure (2021) Vol. 1254, pp. 132244-132244
Closed Access | Times Cited: 12
Role of serendipity in the discovery of classical antidepressant drugs: Applying operational criteria and patterns of discovery
Francisco López‐Muñoz, Pilar D’Ocón, Alejandro Romero, et al.
World Journal of Psychiatry (2022) Vol. 12, Iss. 4, pp. 588-602
Open Access | Times Cited: 8
Novel C7-Substituted Coumarins as Selective Monoamine Oxidase Inhibitors: Discovery, Synthesis and Theoretical Simulation
Dong Wang, Ren-Yuan Hong, Mengyao Guo, et al.
Molecules (2019) Vol. 24, Iss. 21, pp. 4003-4003
Open Access | Times Cited: 12
Application of monoamine oxidase in organic synthesis
Yuheng Shao, Ya-Dong Gao, Zhao-Lin He, et al.
Chem Catalysis (2024) Vol. 4, Iss. 10, pp. 101068-101068
Closed Access | Times Cited: 1
Targeting MAO-B with Small-Molecule Inhibitors: A Decade of Advances in Anticancer Research (2012–2024)
Iyman Alsaad, Dalil Rahman, Ola Al-Tamimi, et al.
Molecules (2024) Vol. 30, Iss. 1, pp. 126-126
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top